Homeright arrow
New Jersey Cannabis Regulatory Commission: High potency THC, Edibles

New Jersey Cannabis Regulatory Commission: High potency THC, Edibles

Mikhail Kogan, MD, ABOIM

Check mark
Expert Testimony
|
date
June 2, 2021
|
Regulatory

Doctors for Cannabis Regulation expert Dr. Mikhail Kogan provides testimony at the New Jersey Cannabis Regulatory Commission meeting held on June 1, 2021.

Share:

About the Author

Mikhail Kogan, MD, ABOIM

Mikhail Kogan, MD, ABOIM

Mikhail Kogan, MD, ABOIM is a leader in the newly established field of Integrative Geriatrics. He is board-certified in Internal Medicine, Geriatrics, Palliative Care, and Integrative Medicine, is the editor of “Integrative Geriatric Medicine” Oxford University Press textbook, and is a frequent speaker on the topics of Integrative Medicine and Geriatrics, healthy aging, neurodegenerative diseases, and use of medical cannabis. Dr. Kogan currently serves as medical director of the GW Center for Integrative Medicine, is the founder and director of the George Washington University Integrative Geriatrics Fellowship Track and the director of the Integrative Medicine Track program at the George Washington University School of Medicine. He also serves as a part-time faculty member of the George Washington Institute for Spirituality and Health and the GW Center for Aging, Health and Humanities. Dr. Kogan has been early adopter of the Washington, D.C. Medical Cannabis program and has been instrumental in the D.C. Rx Medical Cannabis education program. He is also the chair of the board of AIM Health Institute, a Washington, D.C based non-profit organization providing integrative medicine services to low-income and terminally ill patients regardless of their ability to pay.